PT - JOURNAL ARTICLE AU - Paul R Scully AU - Thomas A Treibel AU - Marianna Fontana AU - Neil Hartman AU - Guy Lloyd AU - Francesca Pugliese AU - Nikant Sabharwal AU - Jim Newton AU - Andrew Kelion AU - Michael Mullen AU - Muhiddin Ozkor AU - Simon Kennon AU - Leon J Menezes AU - Philip N Hawkins AU - James C Moon TI - 1 A multi-centre study of cardiac amyloidosis in tavi patients AID - 10.1136/heartjnl-2018-BCVI.42 DP - 2018 May 01 TA - Heart PG - A15--A15 VI - 104 IP - Suppl 5 4099 - http://heart.bmj.com/content/104/Suppl_5/A15.2.short 4100 - http://heart.bmj.com/content/104/Suppl_5/A15.2.full SO - Heart2018 May 01; 104 AB - Background Aortic stenosis (AS) is common, affecting nearly 3% of those aged over 75. Once symptomatic with severe AS outcomes are poor without intervention. An under-recognised restrictive cardiomyopathy in the elderly is wild-type transthyretin amyloid, with deposits found in up to 25% of those aged over 85 at autopsy. Bone scintigraphy offers a reliable non-invasive method of diagnosis. Dual pathology is likely to be an important disease modifier in the elderly undergoing transcatheter aortic valve implantation (TAVI).Methods This work forms part of the ATTRact-AS multi-centre study (NCT03029026), which seeks the prevalence of cardiac amyloid in the elderly (aged ≥75) with severe AS referred for TAVI. Participants underwent 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scintigraphy prior to TAVI, which was graded using the Perugini scoring system. All DPD-positive patients were referred onto the National Amyloidosis Centre.Results 125 patients were recruited between October 2016 and January 2018 (aged 86±5 years, 44% male). At baseline the aortic valve peak velocity was 4.19±0.66 m/s, mean gradient 43±15 mmHg and area 0.40±0.11 cm2. Left ventricular ejection fraction was 53%±11% and mean septal wall thickness 13±2 mm (range 6–21 mm). DPD scintigraphy was positive in 16 patients (13%, 95% CI: 8% to 20%). Perugini grade was 1 (n=5) and 2 (n=11). In the DPD-positive cohort 44% were male (aged 88±5 years) and those genotyped were all wild-type (n=7).Discussion We have built on the recently published interim results of the ATTRact-AS study. Our findings from two centres suggest that 13% of elderly patients referred for TAVI with AS have occult cardiac amyloidosis.